The purpose of this study was to investigate the validity and reliability of Singaporean language versions (English and Chinese) of the EQ-5D self-report questionnaire (EQ-5D) in patients with Parkinson's disease. METHODS: Patients with Parkinson's disease recruited from a patient support group and a hospital outpatient clinic completed a questionnaire containing the EQ-5D and the Parkinson's disease questionnaire (PDQ-39) twice in a 2-week period. Test-retest reliability was assessed for EQ-5D items, utility index and visual analog scale (EQ-VAS) using Cohen's kappa or intraclass correlation coefficients (ICC). Construct validity of EQ-5D utility and EQ-VAS scores was assessed using Spearman's rank correlations between EQ-5D and PDQ-39 summary index (PDQ-39SI) scores. RESULTS: One hundred fifty subjects (English-speaking: n = 87) completed baseline and 106 subjects (English-speaking: n = 68) completed follow-up questionnaires (median interval: 12 days). Kappa values of EQ-5D items ranged from 0.58 to 0.75 (English version) and from 0.38 to 0.55 (Chinese version). ICC values for utility/ EQ-VAS scores were 0.78/ 0.83 (English version) and 0.62/ 0.72 (Chinese version) respectively. Spearman's correlation coefficients between utility/ EQ-VAS scores and the PDQ-39SI were -0.66/ -0.45 (English version) and -0.76/ -0.44 (Chinese version) respectively (p < 0.001 for all). CONCLUSION: Both Singaporean English and Chinese EQ-5D versions appear to be valid and reliable outcome measures for Singaporeans with Parkinson's disease.
OBJECTIVE:
The purpose of this study was to investigate the validity and reliability of Singaporean language versions (English and Chinese) of the EQ-5D self-report questionnaire (EQ-5D) in patients with Parkinson's disease. METHODS: Patients with Parkinson's disease recruited from a patient support group and a hospital outpatient clinic completed a questionnaire containing the EQ-5D and the Parkinson's disease questionnaire (PDQ-39) twice in a 2-week period. Test-retest reliability was assessed for EQ-5D items, utility index and visual analog scale (EQ-VAS) using Cohen's kappa or intraclass correlation coefficients (ICC). Construct validity of EQ-5D utility and EQ-VAS scores was assessed using Spearman's rank correlations between EQ-5D and PDQ-39 summary index (PDQ-39SI) scores. RESULTS: One hundred fifty subjects (English-speaking: n = 87) completed baseline and 106 subjects (English-speaking: n = 68) completed follow-up questionnaires (median interval: 12 days). Kappa values of EQ-5D items ranged from 0.58 to 0.75 (English version) and from 0.38 to 0.55 (Chinese version). ICC values for utility/ EQ-VAS scores were 0.78/ 0.83 (English version) and 0.62/ 0.72 (Chinese version) respectively. Spearman's correlation coefficients between utility/ EQ-VAS scores and the PDQ-39SI were -0.66/ -0.45 (English version) and -0.76/ -0.44 (Chinese version) respectively (p < 0.001 for all). CONCLUSION: Both Singaporean English and Chinese EQ-5D versions appear to be valid and reliable outcome measures for Singaporeans with Parkinson's disease. The most essential were changes in the following subscales of PDQ-39: "Mobility", "Activities of Daily Living", "Emotional well being" (p < .01) and "Stigma" (p < .05). Changes in the others subscales were not significant. Advanced PD patients also demonstrated positive changes on piribedil treatment: 7.0% decrease of UPDRS values (p < .05) per one year and 7.7% of PDQ-39 values (p < .05) per 1 year. Patients had significant improvement only in subscales "Mobility" and "Activities of Daily Living" (p < .05). CONCLUSIONS: Addition of piribedil improves quality of life in PD patients. More expressed improvements in quality of life is observed in early PD patients in Russia. The management of a chronic disease must integrate the needs induced by the disease on the patient's surroundings. OBJECTIVE: The objective of the COMPAS study is to assess the socio-economic consequences on the daily life of the spouse of a patient diagnosed with Parkinson's disease and to identify their worries and needs. METHODS: Self-administered questionnaires, created on the basis of interviews with the spouses of parkinson patients, were sent to general practitioners, neurologists as well as to members of patients' associations (Franceparkinson), who then distributed them to the families concerned. RESULTS: The results concerned a population of 1013 spouses. Patients had been diagnosed since 10.4 years on average at the age of 58.8 years old. The spouse is often a woman (66%), retired (68%) and more than 70 years old (40%). She is the only person looking after the patient (49%). She spends on average 7.5 hours per day in taking care of the patient. This high level of involvement greatly modifies her daily life : specific organ-
PNM21

PIRIBEDIL IMPROVES QUALITY OF LIFE IN PATIENTS WITH PARKINSON'S DISEASE IN
PNM22
SOCIO-ECONOMIC IMPACT OF PARKINSONS DISEASE ON SPOUSES: THE COMPAS STUDY
